Psychotropics India

Psychotropics India Limited, founded in 1987, is a rapidly growing pharmaceutical company in India. It specializes in producing high-quality, affordable medicines for Indian and international markets. The company offers a diverse range of products: generic, ethical, critical care, and animal health solutions. With a strong focus on research and innovation, Psychotropics India is dedicated to enhancing patient care and ensuring quality throughout manufacturing. It operates within Healthcare and Pharmaceuticals, leveraging expertise to meet varied medical needs.

Operating with 500-1,000 employees, Psychotropics India demonstrates significant operational capacity. Their commitment to growth and market presence is evident in diverse product offerings and dedication to quality assurance. Manufacturing processes adhere to high standards, ensuring product efficacy and safety. The company's recent e-commerce website launch signifies a forward-thinking approach to client accessibility. Meet Psychotropics India's team to gain insight into their leadership and workforce driving these operations.

Psychotropics India Limited's market strategy targets healthcare requirements from lifestyle and dermatology to critical care. Their commitment to affordability without compromising quality is a key differentiator in the competitive Indian pharmaceutical landscape. Product forms include syrups and large-volume parenterals. Hashtags like #b2b, #b2c, #india, and #asiapacific reflect extensive market engagement. With a revenue of $167.5M, Psychotropics India is positioned for continued expansion and innovation in the global pharmaceutical sector.